BMS-986165 manufacturers
- BMS-986165 API
-
- $100.00 / 1KG
-
2024-04-26
- CAS:1609392-27-9
- Min. Order: 1KG
- Purity: 99.9%
- Supply Ability: 500
- Deucravacitinib
-
- $15.00 / 100g
-
2024-04-26
- CAS:1609392-27-9
- Min. Order: 100g
- Purity: 99.9%
- Supply Ability: 1000kg
- BMS-986165
-
- $0.00 / 1KG
-
2023-11-27
- CAS:1609392-27-9
- Min. Order: 1KG
- Purity: 99% min
- Supply Ability: 20 TONS
|
| | BMS-986165 Basic information | | Uses |
| Product Name: | BMS-986165 | | Synonyms: | Tyk2-IN-4;TYK2-IN-4;BMS986165;BMS-986165;BMS 986165;Deucravacitinib(BMS986165);Deucravacitinib (TYK2-IN-4;6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H?)methylpyridazine-3-carboxamide;DeucravacitinibQ: What is
Deucravacitinib Q: What is the CAS Number of
Deucravacitinib;6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl) phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide;Deucravacitinib | | CAS: | 1609392-27-9 | | MF: | C20H22N8O3 | | MW: | 422.45 | | EINECS: | | | Product Categories: | API;APIS;API | | Mol File: | 1609392-27-9.mol |  |
| | BMS-986165 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 1 mg/ml; DMSO: 1 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.33 mg/ml | | form | A crystalline solid |
| | BMS-986165 Usage And Synthesis |
| Uses | BMS-986165 is a novel oral selective TYK2 inhibitor with a unique mechanism of action that is expected to provide a promising oral option to help patients effectively manage their psoriasis. | | Uses | Deucravacitinib is a tyrosine kinase 2 inhibitor which can be useful in the treatment of systemic lupus erythematosus. |
| | BMS-986165 Preparation Products And Raw materials |
|